HRAS | KRAS | NRAS | |||||||
Nevus type | Mutation analyses* | G13R | G12D | G12C | Other¶ | G12D | G12V | Other¶ | Other¶ |
Keratinocytic | |||||||||
KEN plus urothelial carcinomasΔ[1] | Sanger sequencing | G12S | – | – | – | – | |||
KEN[2] | SNaPshot assay, Sanger sequencing | 21/72 | 1/72 | G12V, Q61L | 1/72 | G12D, P34L, Q61R | FGFR3 (16/72), PIK3CA (6/72) | ||
KEN plus rhabdomyosarcomaΔ[3] | WGA-aCGH | 1/1 | |||||||
Sebaceous | |||||||||
Schimmelpenning syndrome, NS[4] | RAS SNaPshot assay, Sanger sequencing | 1/2 59/65 | 1/65 | 1/65 | G12S (3/65), A11S | 1/2 2/65 | 1/65 | ||
NS◊[5] | WES of index cases, Sanger sequencing | 25/27 | 1/27 | 1/27 | |||||
Schimmelpenning syndrome (index), NS[6] | WES of index case, Sanger sequencing | 1/1 24/31 | 1/31 | 2/31 | |||||
PPK | |||||||||
Nevus spilus plus NS[7] | RAS SNaPshot assay, Sanger sequencing | 4/6 | G61R (2/6) | ||||||
Melanocytic | |||||||||
Agminated segmental neviΔ[8] | Sanger sequencing | 1/1 | BRAF V600E | ||||||
Nevus spilus plus overlying agminated Spitz neviΔ[9] | WES-aCGH | 1/1 | Copy number increase in chromosome 11p in overlying Spitz nevi | ||||||
Nevus spilus[10] | Sanger sequencing | 8/8 | – | – | – | – | |||
Nevus spilus-type CMN[11] | WES | G13R, Q61H (2/3) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟